Buisness Line
Business Daily from THE HINDU group of publicationsWednesday, Feb 21, 2007
Mumbai, Feb 20
Lupin Ltd has entered into an agreement with Laboratoires Servier of France for the sale of certain patent applications and related intellectual property (IP) of blood-pressure drug Perindopril for multiple countries, the company told the Bombay Stock Exchange. No financial details were divulged. Lupin shares were marginally down at Rs 585.80 on the BSE.
http://www.blonnet.com/2007/02/21/stories/2007022101710200.htm
For any querry:-
09896868668
deepakmiglani@gmail.com
No comments:
Post a Comment